en
Pharmaceuticals
Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
A C D E F G I L M N P R S T V X Z
Famvir*
(famciclovir)
Antiviral Agent
*Famvir is a registered trademark
Femara*
(letrozole)
Non-steroidal aromatase inhibitor; Inhibitor of estrogen biosynthesis; Anti-tumour agent
Important information for healthcare professionals (2006)
Important information for healthcare professionals (2005)
*Femara is a registered trademark
Fiorinal*
(ASA-caffeine-butalbital)
Analgesic-Sedative
*Fiorinal is a registered trademark
Fiorinal*-C 1/4, 1/2
(ASA-caffeine-codeine-butalbital)
Analgesic-Sedative
*Fiorinal is a registered trademark
Foradil*
(formoterol fumarate)
Bronchodilator
Important information for healthcare professionals (2005)
*Foradil is a registered trademark
Research
Novartis is one of the industry’s biggest investors in research.
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Sandoz
Sandoz is one of the leaders in the development, manufacturing and distribution of generic pharmaceutical products.